Iloprost Injection, for intravenous use

( DrugBank: Iloprost / KEGG DRUG: Iloprost )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	2

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04040322 (ClinicalTrials.gov)	October 14, 2019	30/7/2019	Intravenous Iloprostin Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosi ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and ...	Raynaud's Phenomenon Secondary to Systemic Sclerosis	Drug: Placebo IV infusion;Drug: Iloprost Injection, for intravenous use	Eicos Sciences, Inc.	NULL	Completed	18 Years	N/A	All	198	Phase 3	United States
2	NCT03867097 (ClinicalTrials.gov)	March 4, 2019	6/3/2019	Intravenous Iloprostin Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosi ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intraven ...	Raynaud Phenomenon Secondary to Systemic Sclerosis	Drug: Placebo IV infusion;Drug: Iloprost Injection, for intravenous use	Eicos Sciences, Inc.	NULL	Completed	18 Years	N/A	All	41	Phase 2	United States

First Previous1Next Last